The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESC 2026 | Is a cancer-specific CHIP risk score required to improve cardio-oncology monitoring?
Jaiveer Singh, MS, Yale University School of Medicine, New Haven, CT, discusses the need for further research into a cancer-specific CHIP risk score to help identify patients who require closer cardio-oncology monitoring, noting that while the risk score developed using data from the UK Biobank is effective in the general population, findings show that this doesn’t translate to a cancer population. This interview took place during the 2026 European Society of Cardiology (ESC) Congress in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
